Athira Pharma, Inc. appointed seasoned finance and corporate strategy executive Andrew Gengos as Chief Financial Officer. Most recently, Mr. Gengos served as the Chief Business Officer at Cyteir Therapeutics and has held executive roles at ImmunoCellular Therapeutics, Neuraltus Pharmaceuticals, AOBiome Therapeutics, and Synlogic. Previously, Mr. Gengos was Vice President of Strategy and Corporate Development at Amgen for eight years.

Mr. Gengos holds a Master of Business Administration from the UCLA Anderson School of Management and a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology.